The global anti-asthmatic drugs market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factor for the growth of the market during the forecast period is the increasing prevalence of asthma across the globe. According to World Health Organization (WHO), asthma is a major noncommunicable disease (NCD) that affects both children and adults globally. It affected an estimated 262 million people and with a mortality rate of 461000 people globally in 2019. Furthermore, asthma is the most common chronic disease among children. This, in turn, is accelerating the demand for anti-asthmatic drugs. Moreover, the market is also growing due to the new product launches and FDA approvals. For instance, in May 2019, Sanofi announced that it received the European Commission approval for Dupixent (dupilumab). It is an anti-ashtmatic drug used in adults and adolescents 12 years and older as add-on maintenance for the treatment of severe asthma with type 2 inflammation.
To Request a Sample of our Report on Anti-Asthmatic Drugs Market: https://www.omrglobal.com/request-sample/anti-asthmatic-drugs-market
Some major players in the market include Novartis International AG, Sanofi SA, and Regeneron Pharmaceuticals, Inc., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in December 2021, Amgen announced the approval of Amgen and AstraZeneca’s Tezspire (tezepelumab-ekko) from the US Food and Drug Administration (FDA). It is used as an add-on maintenance treatment of severe asthma in adult and pediatric patients of age 12 years and older.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
Segment Covered-
- By Type
- By Application
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape– Novartis International AG, Sanofi SA, and Regeneron Pharmaceuticals, Inc., among others.
(Get 15% Discount on Buying this Report)
A full Report of Anti-Asthmatic Drugs Market is Available @ https://www.omrglobal.com/industry-reports/anti-asthmatic-drugs-market
Global Anti-Asthmatic Drugs Market Report by Segment
By Type
- Long-term Control Medications
- Quick-relief Medications (Rescue Medications)
- Medications for Allergy-induced Asthma
By Application
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Global Anti-Asthmatic Drugs Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
